Tickerplace logo

Tickerplace

Avidity Biosciences, Inc. (RNA): calculated intrinsic value vs market price

Calculated intrinsic value vs market price

Avidity Biosciences, Inc. (RNA) current market price $13.77; calculated gap vs modeled fair value is 192.90%. The dollar intrinsic value estimate is available with Tickerplace Pro.

  • Fair value gap (live) 192.90% (from live valuation API)
  • Confidence (live) 9.5/10 (Large gap)

Confidence score is based on the magnitude of the gap vs the modeled estimate.

Fair value estimate

Unlock fair value

Current price

$13.77

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE CalculatorStock Valuation Calculator

How to read the price vs calculated fair value gap for Avidity Biosciences, Inc.

For Avidity Biosciences, Inc., intrinsic value ties fair value to sustainable cash generation and compares that level with the live market price.

Historical valuation for RNA shows cycles where multiples expanded and compressed; today’s positioning is one data point in that range.

The gap comes down to growth, risk, and return on capital in the models. Cross-check with live ratios and financials linked from this page.

Key metrics

P/E ratio
43.6x
Revenue growth (TTM y/y)
22%
Profit margin
22.8%
Fair value (model)
Unlock

Next steps

Frequently asked questions — RNA

What is RNA’s calculated intrinsic value vs its market price?

Avidity Biosciences, Inc. (RNA) current market price is $13.77, a calculated difference of 192.9% versus modeled fair value. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.

What is Avidity Biosciences, Inc.'s intrinsic value?

Intrinsic value is an estimate of what RNA shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Avidity Biosciences, Inc.'s intrinsic value calculated?

Tickerplace calculates RNA's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.

How should I read RNA’s fair value gap?

RNA’s calculated gap versus modeled fair value is 192.9% at a market price of $13.77. A gap is a calculated difference between price and the model estimate, not a buy or sell conclusion. Confirm with ratios and financials on the company profile.